Part D Marketing Guidelines Please APhA; Vendor Fees Uncoupled From Risk
Executive Summary
CMS is clarifying that it need not review comparative data that pharmacies use to market Medicare Part D prescription drug plans, so long as the materials stem from an "objective" source
You may also be interested in...
Medicare Rx Marketing: Pharmacists Seek To Make Plan Recommendations
Disclosure of financial interest in a Medicare Part D prescription drug plan should be a sufficient safeguard to allow pharmacies to make direct comparisons and recommend specific plans to beneficiaries, retail drug stores are telling the Centers for Medicare & Medicaid Services
Medicare Part D Marketing Guidelines Prohibit Direct Plan Comparisons
Medicare prescription drug plans will not be allowed to make direct comparisons to competing plans in their promotional activities, marketing guidelines issued by the Centers for Medicare & Medicaid Services state
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011